Drugplain

RIXUBIS

COAGULATION FACTOR IX (RECOMBINANT) · KIT · Takeda Pharmaceuticals America, Inc.

No Recall History
Plain English

Rixubis is a blood clotting protein used to treat or prevent bleeding in people with hemophilia B (a bleeding disorder where the body lacks clotting factor IX). It is given by injection as directed by your healthcare provider.

Key Facts

Brand Name
RIXUBIS
Generic Name
COAGULATION FACTOR IX (RECOMBINANT)
NDC Code (Product)
0944-3032
Manufacturer
Takeda Pharmaceuticals America, Inc.
Dosage Form
KIT
Marketing Status
Application #
BLA125446
Marketing Start
10/04/2013

Recall History

No Recall History

Frequently Asked Questions

What is RIXUBIS used for?

Rixubis is a blood clotting protein used to treat or prevent bleeding in people with hemophilia B (a bleeding disorder where the body lacks clotting factor IX). It is given by injection as directed by your healthcare provider.

Is RIXUBIS a controlled substance?

RIXUBIS is not classified as a controlled substance by the DEA.

What is the generic name for RIXUBIS?

The generic name for RIXUBIS is COAGULATION FACTOR IX (RECOMBINANT). There are 9 other brand versions of COAGULATION FACTOR IX (RECOMBINANT).

What is the NDC code for RIXUBIS ?

The NDC (National Drug Code) for RIXUBIS is 0944-3032, listed by Takeda Pharmaceuticals America, Inc..

Product NDC

0944-3032

Package NDC

0944-3032-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)